RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105

加皇资本市场维持Encompass Health(EHC.US)买入评级，上调目标价至105美元

moomoo资讯 · 09/26 07:33 · 评级/大行评级

RBC Capital analyst Ben Hendrix maintains $Encompass Health (EHC.US)$ with a buy rating, and adjusts the target price from $95 to $105.

According to TipRanks data, the analyst has a success rate of 62.2% and a total average return of 11.9% over the past year.

AnalystRecentRatingAutoNews_75299366848403_20240926_408f7e57840b518f63a81329bb256a5dd03acaad_1727357461604220_mm_en

Furthermore, according to the comprehensive report, the opinions of $Encompass Health (EHC.US)$'s main analysts recently are as follows:

Encompass Health has conveyed a positive stance regarding ongoing business tendencies and anticipates further growth in demand for its services. This follows a noteworthy streak where the company has consistently experienced a growth in same store discharges exceeding 4% for eight successive quarters, aligning with the upper threshold of their 2%-4% goal. Management, while not elaborating on the third-quarter performance, highlighted certain factors that might benefit the current yearly forecast. One such point is the assumption that new facilities will take longer to reach positive EBITDA compared to the previous year; however, if these facilities achieve a ramp-up rate similar to last year, it could signify potential upside.
The firm is revising its projections based on the company's Q2 earnings outperformance reported last month. It anticipates a persistent robust demand for post-acute services, supported by strong hospital admission growth projected by operators in the coverage through the end of the year, in addition to high hospital inpatient acuity and an enhancement in the length of stay.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

加皇资本市场分析师Ben Hendrix维持$Encompass Health (EHC.US)$买入评级，并将目标价从95美元上调至105美元。

根据TipRanks数据显示，该分析师近一年总胜率为62.2%，总平均回报率为11.9%。

AnalystRecentRatingAutoNews_75299366848403_20240926_408f7e57840b518f63a81329bb256a5dd03acaad_1727357461604220_mm_sc

此外，综合报道，$Encompass Health (EHC.US)$近期主要分析师观点如下：

Encompass Health对持续的业务趋势表示了积极的立场，并预计对其服务的需求将进一步增长。在此之前，该公司的同店出货量连续八个季度持续增长超过4％，与其2％-4％的目标上限持平。管理层虽然没有详细说明第三季度的业绩，但强调了可能有利于当前年度预测的某些因素。其中之一是假设新设施与去年相比需要更长的时间才能达到正的息税折旧摊销前利润；但是，如果这些设施实现与去年相似的增长率，则可能意味着潜在的上升空间。
该公司正在根据该公司上个月公布的第二季度收益跑赢大盘来修改其预测。它预计，对急症后服务的需求将持续强劲，这得益于运营商预计到年底的住院人数将实现强劲增长，此外住院患者敏锐度高，住院时间也将延长。

提示:

TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。

TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。

分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。

总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105

RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105

风险及免责提示

声明